Your browser doesn't support javascript.
loading
Modified FOLFIRINOX versus gemcitabine plus oxaliplatin as first-line chemotherapy for patients with locally advanced or metastatic cholangiocarcinoma: a retrospective comparative study.
Zou, Lu; Li, Xuechuan; Wu, Xiangsong; Cui, Jiujie; Cui, Xuya; Song, Xiaoling; Ren, Tai; Han, Xusheng; Zhu, Yidi; Li, Huaifeng; Wu, Wenguang; Wang, Xu'an; Gong, Wei; Wang, Liwei; Li, Maolan; Lau, Wan Yee; Liu, Yingbin.
Afiliação
  • Zou L; Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
  • Li X; Department of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
  • Wu X; Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, 200092, China.
  • Cui J; Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200032, China.
  • Cui X; Department of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
  • Song X; Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, 200092, China.
  • Ren T; Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200032, China.
  • Han X; Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
  • Zhu Y; Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, 200092, China.
  • Li H; Department of Medical Oncology, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai, 200127, China.
  • Wu W; Department of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
  • Wang X; Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, 200092, China.
  • Gong W; Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200032, China.
  • Wang L; Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
  • Li M; Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, 200092, China.
  • Lau WY; Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
  • Liu Y; Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, 200092, China.
BMC Cancer ; 21(1): 818, 2021 Jul 16.
Article em En | MEDLINE | ID: mdl-34266407
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Colangiocarcinoma / Desoxicitidina / Oxaliplatina Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Colangiocarcinoma / Desoxicitidina / Oxaliplatina Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China